Nellore Oncology Consortium Private Limited - Company Profile

It is a healthcare private limited company based in Nellore, Andhra Pradesh, India, established in 2016.
2016 Nellore, Andhra Pradesh, India Struck Off
Last Updated:
Access Report
About Nellore Oncology Consortium Private Limited

Nellore Oncology Consortium Private Limited, a struck off private limited company, was established on 22 September 2016 in Nellore, Andhra Pradesh, India. Engaging in hospital services within the hospital and medical care sector, it holds CIN: U85300AP2016PTC104126. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.

It upholds a compliant status. Its leadership includes Ramesh Maturi (Director), Shankar Vangipuram Radha Krishna Gowri (Director), Haritha Chiramana (Director). Past directors included Annam Sharath, Anil Krishna Gundala. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at 17-2-163 Kavita Nursing Home Opposite Bsnl Office, Leela Mahal Center, Nellore, Andhra Pradesh, 524003.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85300AP2016PTC104126

  • Registration Number

    104126

  • Incorporation Date

    22 September 2016

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹1.50 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 1.50 M
  • Company Age 9 Year, 6 Months
  • Last Filing with ROC 31 Mar 2019
Company report

Nellore Oncology Consortium Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nellore Oncology Consortium Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nellore Oncology Consortium Private Limited?
Current Directors
Name Designation Appointment Date Status
Ramesh Maturi Director 22 Sep 2016 Current
Shankar Vangipuram Radha Krishna Gowri Director 22 Sep 2016 Current
Haritha Chiramana Director 24 Jun 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 07 Jan 2020 Past
Pramod Abcsdd Additional Director 24 Oct 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nellore Oncology Consortium.

Nellore Oncology Consortium Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Nellore Oncology Consortium revenue growth over time
Nellore Oncology Consortium profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nellore Oncology Consortium?

In 2017, Nellore Oncology Consortium had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Nellore Oncology Consortium?

Unlock and access historical data on people associated with Nellore Oncology Consortium, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nellore Oncology Consortium, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nellore Oncology Consortium's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nellore Oncology Consortium
Recent Activity within the Organization
  • Annual General Meeting

    The activity Nellore Oncology Consortium Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Nellore Oncology Consortium Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Vijayawada. was completed.

  • Director Appointment

    The activity Haritha Chiramana was appointed as a Director was appointed as a Director on 24 Jun 2017 & has been associated with this company since 8 years 9 months . was completed.

  • Director Appointment

    Ramesh Maturi was appointed as a Director was appointed as a Director on 22 Sep 2016 & has been associated with this company since 9 years 6 months . was recorded as a recent event.

  • Director Appointment

    Progress on Shankar Vangipuram Radha Krishna Gowri was appointed as a Director was appointed as a Director on 22 Sep 2016 & has been associated with this company since 9 years 6 months . was documented.

  • Company Incorporation

    The activity Nellore Oncology Consortium Private Limited was registered on 22 Sep 2016 with Roc Vijayawada & aged 9 years 6 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nellore Oncology Consortium Private Limited?

The CIN of Nellore Oncology Consortium Private Limited is U85300AP2016PTC104126.

Where is Nellore Oncology Consortium Private Limited headquartered?

Nellore Oncology Consortium Private Limited is headquartered at 17-2-163 Kavita Nursing Home Opposite Bsnl Office, Leela Mahal Center, Nellore, Andhra Pradesh, 524003.

When was Nellore Oncology Consortium Private Limited incorporated?

Nellore Oncology Consortium Private Limited was incorporated on 22 September 2016.

Who are the current directors of Nellore Oncology Consortium Private Limited?

The current directors of Nellore Oncology Consortium Private Limited are

What is the primary industry of Nellore Oncology Consortium Private Limited?

The primary industry of Nellore Oncology Consortium Private Limited is Hospital And Medical Care.

Is Nellore Oncology Consortium Private Limited a listed company?

Nellore Oncology Consortium Private Limited is unlisted.

What is the capital structure of Nellore Oncology Consortium Private Limited?

The authorized capital of Nellore Oncology Consortium Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.

What is the compliance status of Nellore Oncology Consortium Private Limited?

The compliance status of Nellore Oncology Consortium Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available